![](/images/general/no_picture/200_user.png)
Hoa T Le
Examiner (ID: 13075, Phone: (571)272-1511 , Office: P/1788 )
Most Active Art Unit | 1788 |
Art Unit(s) | 1794, 1787, 1316, 2899, 1773, 1788, 1509, 1709 |
Total Applications | 2557 |
Issued Applications | 1900 |
Pending Applications | 185 |
Abandoned Applications | 471 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 18526358
[patent_doc_number] => 11713344
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Acylated oxyntomodulin peptide analog
[patent_app_type] => utility
[patent_app_number] => 17/410697
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 27
[patent_no_of_words] => 11158
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/410697 | Acylated oxyntomodulin peptide analog | Aug 23, 2021 | Issued |
Array
(
[id] => 17685891
[patent_doc_number] => 20220193183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE
[patent_app_type] => utility
[patent_app_number] => 17/390165
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390165 | COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE | Jul 29, 2021 | Pending |
Array
(
[id] => 17355423
[patent_doc_number] => 20220016219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Means and Methods to Treat Diabetes
[patent_app_type] => utility
[patent_app_number] => 17/387788
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17387788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/387788 | Means and Methods to Treat Diabetes | Jul 27, 2021 | Pending |
Array
(
[id] => 17213122
[patent_doc_number] => 20210346458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN
[patent_app_type] => utility
[patent_app_number] => 17/384478
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384478
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384478 | COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN | Jul 22, 2021 | Abandoned |
Array
(
[id] => 17414044
[patent_doc_number] => 20220048948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => CD40 TARGETED PEPTIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/380303
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380303
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/380303 | CD40 TARGETED PEPTIDES AND USES THEREOF | Jul 19, 2021 | Pending |
Array
(
[id] => 17213032
[patent_doc_number] => 20210346368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/379369
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2855
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/379369 | ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS | Jul 18, 2021 | Pending |
Array
(
[id] => 17198687
[patent_doc_number] => 20210338781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/366453
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17366453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/366453 | METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY | Jul 1, 2021 | Pending |
Array
(
[id] => 17299470
[patent_doc_number] => 20210395309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => PEPTIDE-DRUG CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/304472
[patent_app_country] => US
[patent_app_date] => 2021-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17304472
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/304472 | PEPTIDE-DRUG CONJUGATES | Jun 21, 2021 | Pending |
Array
(
[id] => 19058973
[patent_doc_number] => 11938166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Methods and compositions for treating mucosal tissue disorders
[patent_app_type] => utility
[patent_app_number] => 17/348096
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 42883
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17348096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/348096 | Methods and compositions for treating mucosal tissue disorders | Jun 14, 2021 | Issued |
Array
(
[id] => 17126220
[patent_doc_number] => 20210300988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => ANTI-KRAS-G12D T CELL RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/345390
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345390 | Anti-KRAS-G12D T cell receptors | Jun 10, 2021 | Issued |
Array
(
[id] => 17482156
[patent_doc_number] => 20220089660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/324501
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324501 | IDENTIFICATION OF MUTATIONS IN CHANNELOPSIN VARIANTS HAVING IMPROVED LIGHT SENSITIVITY AND METHODS OF USE THEREOF | May 18, 2021 | Pending |
Array
(
[id] => 17098180
[patent_doc_number] => 20210285971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => USE OF Ass34 TO ASSESS ALZHEIMER'S DISEASE PROGRESSION
[patent_app_type] => utility
[patent_app_number] => 17/323312
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323312 | USE OF Ass34 TO ASSESS ALZHEIMER'S DISEASE PROGRESSION | May 17, 2021 | Pending |
Array
(
[id] => 17314556
[patent_doc_number] => 20210403604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Liposome Binding Peptide, Construct for Manufacturing the Liposome Binding Peptide, and Liposome
[patent_app_type] => utility
[patent_app_number] => 17/315041
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17315041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/315041 | Liposome Binding Peptide, Construct for Manufacturing the Liposome Binding Peptide, and Liposome | May 6, 2021 | Pending |
Array
(
[id] => 17126209
[patent_doc_number] => 20210300977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/244973
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244973 | CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME | Apr 29, 2021 | Abandoned |
Array
(
[id] => 17243462
[patent_doc_number] => 20210363205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => METHODS FOR TREATING MYELIN ASSOCIATED DISEASES AND MITOCHONDRIA ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/246549
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246549 | Methods for treating myelin associated diseases and mitochondria associated diseases | Apr 29, 2021 | Issued |
Array
(
[id] => 17414042
[patent_doc_number] => 20220048946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => CYCLIC TETRAPEPTIDE STEREOISOMERS
[patent_app_type] => utility
[patent_app_number] => 17/240638
[patent_app_country] => US
[patent_app_date] => 2021-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240638
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/240638 | CYCLIC TETRAPEPTIDE STEREOISOMERS | Apr 25, 2021 | Abandoned |
Array
(
[id] => 18887756
[patent_doc_number] => 11866518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Bicyclic peptide ligands specific for TSLP
[patent_app_type] => utility
[patent_app_number] => 17/223244
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20873
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223244 | Bicyclic peptide ligands specific for TSLP | Apr 5, 2021 | Issued |
Array
(
[id] => 18028950
[patent_doc_number] => 11512123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => Method for removing water from compound solution and performing conjugate acid conversion
[patent_app_type] => utility
[patent_app_number] => 17/184164
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4895
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184164
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184164 | Method for removing water from compound solution and performing conjugate acid conversion | Feb 23, 2021 | Issued |
Array
(
[id] => 16932440
[patent_doc_number] => 20210198329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => PEPTIDES FOR TARGETING LRP6-OVEREXPRESSED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/175704
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175704
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175704 | Peptides for targeting LRP6-overexpressed cells | Feb 14, 2021 | Issued |
Array
(
[id] => 18619110
[patent_doc_number] => 11752132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => Materials and methods for improving gastrointestinal function
[patent_app_type] => utility
[patent_app_number] => 17/161811
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 46
[patent_no_of_words] => 22526
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161811
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/161811 | Materials and methods for improving gastrointestinal function | Jan 28, 2021 | Issued |